Biocartis
Biocartis Group NV is a molecular diagnostics company headquartered in Mechelen, Belgium, established in 2007. The company focuses on enhancing clinical practice through its proprietary Idylla platform, which utilizes real-time polymerase chain reaction technology to provide critical molecular information for oncology. Biocartis offers a range of diagnostic tests, including solid biopsy assays for mutations such as BRAF, KRAS, NRAS, and EGFR, as well as plasma liquid biopsy tests. Their products support treatment selection and monitoring in cancer care. The company collaborates with pharmaceutical partners like AstraZeneca and Bristol-Myers Squibb to develop companion diagnostics that align with specific therapies. By integrating molecular and immunodiagnostic technologies, Biocartis aims to improve the efficacy and affordability of personalized medical treatments, serving patients, clinicians, and healthcare providers alike.
GeneproDX, a molecular diagnostics company, develops ThyroPrint, a diagnostic test for thyroid cancer. The company was founded in 2014 and is based in Santiago, Chile.
Immunexpress Pty Ltd is a molecular diagnostics company based in Brisbane, Australia, with an additional office in Seattle, Washington. Founded in 2006, the company specializes in developing clinical assays aimed at the early detection and management of sepsis, particularly in patients at risk. Immunexpress focuses on the discovery and clinical validation of genomic and proteomic biomarkers, translating these findings into diagnostic and monitoring assays suitable for point-of-care applications. Its key products include SeptiCyte Triage, designed for screening sepsis in emergency and intensive care units; SeptiCyte STAT, which monitors high-risk patients in ICUs and post-operative wards; and SeptiCyte RTT, a tool for assessing the immune status of ICU patients with sepsis. The approach taken by Immunexpress utilizes blood gene expression to quantify the immune response to pathogens, moving away from traditional methods that seek to identify the causative pathogen.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.